Intervention trials for adults with bipolar disorder in low-income and lower-middle-income countries: A systematic review
- PMID: 35605708
- DOI: 10.1016/j.jad.2022.05.097
Intervention trials for adults with bipolar disorder in low-income and lower-middle-income countries: A systematic review
Abstract
Background: The treatment gap for bipolar disorder is aggravated by economic inequality. Around half of the world's population live in a low-or lower-middle-income country, where research on treatment is scarce. Hence, this review aims to determine the number and types of intervention studies conducted on adults with bipolar disorder in low-income and lower-middle-income countries and analyze the effect of these interventions on symptom severity, medical adherence, and quality of life.
Methods: A systematic review was conducted in June and November 2021 using eight databases. Controlled intervention trials on adults with bipolar disorder on data from low-income and lower-middle-income countries at time of publication were included. The risk of bias was assessed using the Revised Cochrane risk-of-bias tool for randomized trials or The Risk Of Bias In Non-randomized Studies of Interventions assessment tool.
Results: Twenty-one studies met the inclusion criteria. These were divided into four subtypes based on the intervention; pharmacotherapy (=12), psychosocial (=7), electroconvulsive therapy (=1), and traditional medicine (=1). Three studies were from low-income countries. A high risk of bias characterized the studies; only four studies reported the procedures used for randomization. Most studies, however, identified a beneficial effect on symptom severity, and in addition, medical adherence could be improved with psychosocial interventions.
Limitations: Heterogeneity across studies prevented any meaningful pooling of data to meta-analyses.
Conclusion: Data for treatment interventions contextualized to the local setting for bipolar disorder remains sparse, particularly from low-resource settings. Further studies are urgently needed to target the treatment gap for bipolar disorder.
Trial registration: PROSPERO: CRD42020170953.
Keywords: Bipolar disorder; Global mental health; Intervention trials; Low-income countries; Low-resource setting; Lower-middle-income countries.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous